Adipose derived stem cells: efficiency, toxicity, stability of BrdU labeling and effects on self-renewal and adipose differentiation.
5-bromo-2-deoxyurudine (BrdU) can be used as a methodological tool for in vivo investigations following in vitro prelabeling of isolated stem cells for subsequent cell tracking within the recipient host. The objective of this study was to determine how useful BrdU may be as a labeling modality for adipose derived stem cells (ASC) by examining BrdU toxicity, BrdU intracellular stability, and potential effects on ASC differentiation. Porcine and human ASC (pASC and hASC, respectively) were labeled with BrdU at 5 or 10 μM for 2, 6, 24, and 48 h. BrdU toxicity and stability over time in monolayer cultures, in 3-D collagen scaffolds implanted to a porcine model and after thawing from long-term storage were evaluated by MTT assays and immunohistochemistry. ASC differentiation was evaluated by Oil Red O staining. BrdU was not cytotoxic at all tested concentrations and incubation times. BrdU color intensity within each cell and the number of ASC labeled with BrdU decreased as a function of both incubation time and BrdU concentrations. Labeling intensities decreased over time and were undetectable after 6 passages for pASC and 4 passages for hASC. In 3-D scaffolds, BrdU-labeled ASC were identifiable after 90 days of in vitro cultures and for 30 days in a porcine model. BrdU did not prevent preadipocyte differentiation and BrdU labeling was still detectable after subsequent thawing after long-term storage of ASC. BrdU is an excellent candidate reagent to label and track ASC that will allow distinction between BrdU-labeled donor cells and host cells. The data provides a foundation for conducting future tissue engineering projects using BrdU-labeled ASC.
Department of Plastic Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. charlotte.lequeux@chu-lyon.fr
Charlotte
C
Lequeux
Georgette
G
Oni
Ali
A
Mojallal
Odile
O
Damour
Spencer A
SA
Brown
D000273:Adipose Tissue / Q000166:cytology*; D000818:Animals; D001973:Bromodeoxyuridine / Q000378:metabolism*; D002454:Cell Differentiation; D006801:Humans; D007150:Immunohistochemistry; D023421:Models, Animal; D013234:Stem Cells / Q000166:cytology*; D013552:Swine
D001973:Bromodeoxyuridine
Biomed Mater Eng. 2008;18(1 Suppl):S87-98
18334726
Metabolism. 1982 Apr;31(4):366-73
7078420
Cell Tissue Bank. 2007;8(3):163-77
17063258
AJR Am J Roentgenol. 2007 Apr;188(4):1101-8
17377054
Stem Cell Rev. 2007 Dec;3(4):265-9
17990127
Keio J Med. 2005 Sep;54(3):132-41
16237275
Cell Physiol Biochem. 2007;20(6):867-76
17982269
J Neurosci Methods. 2009 Feb 15;177(1):149-59
19007815
Brain Res. 2008 Jun 18;1215:11-9
18468584
Mol Biol Cell. 2002 Dec;13(12):4279-95
12475952
Biochimie. 2005 Jan;87(1):125-8
15733747
Wound Repair Regen. 2007 Jul-Aug;15(4):505-10
17650094
Biochem Biophys Res Commun. 2009 Jan 16;378(3):539-44
19056354
Biochem Biophys Res Commun. 2006 Mar 17;341(3):882-8
16442498
Plast Reconstr Surg. 2009 Feb;123(2 Suppl):56S-64S
19182664
J Cell Physiol. 2003 Nov;197(2):251-60
14502565
Cytotherapy. 2009;11(6):793-803
19878065
Plast Reconstr Surg. 2008 Jan;121(1):50-58
18176205
Biochem Biophys Res Commun. 2005 Jul 1;332(2):370-9
15896706
Wound Repair Regen. 2006 May-Jun;14(3):325-35
16808812
Ann Plast Surg. 2009 Mar;62(3):317-21
19240532
Cells Tissues Organs. 2006;184(3-4):117-27
17409737
Tissue Eng. 2001 Apr;7(2):211-28
11304456
Brain Res. 1988 Aug 2;457(1):44-52
3167568
Neuroreport. 2001 Mar 5;12(3):559-63
11234763
Pharmacol Rev. 1977 Dec;29(4):249-72
364496
Mol Cell Biochem. 2006 Oct;291(1-2):1-10
16718363
Arch Mal Coeur Vaiss. 2005 Sep;98(9):922-6
16231580
J Urol. 2005 Nov;174(5):2041-5
16217390
Ann Oncol. 1994 Sep;5(7):627-34
7993839
J Dermatol Sci. 2010 Apr;58(1):36-42
20194005
Biomed Mater Eng. 2009;19(4-5):283-91
20042795
Brain Res Rev. 2007 Jan;53(1):198-214
17020783
Hippocampus. 2006;16(3):216-24
16421862
Plast Reconstr Surg. 2006 Sep;118(3 Suppl):121S-128S
16936551